semaglutide bpc 157 b6 Can You Take BPC-157 with GLP-1 Medications (Semaglutide)? Semaglutide/BPC – 157

CagriSema produced unprecedented mean weight loss of 20.4% at 68 weeks on an intent-to-treat basis, significantly exceeding semaglutide alone (14.9%), cagrilintide alone (11.5%), and placebo (3.0%)

Hsieh et al., 2017) (see The Effect on Other Tissues Healing as Support )

REDEFINE 1 Trial Finds CagrilintideSemaglutide Combo Delivers Over 20% Weight Loss in Majority of Patients

"Health Canada won't approve it as a drug, but it slips through as a compounded natural health product, where the federal safety check basically doesn't happen." Health Canada considers NHP compounding within a practitioner-patient relationship distinct from manufacturing and not subject to the same regulatory oversight

The combination isn't FDA-approved and is only available through research studies with strict eligibility criteria